| Definium Therapeutics, Inc. |
Chief Financial Officer |
Common Shares |
150,000 |
$2,008,530 |
$13.39 |
03 Feb 2026 |
Direct |
| Longboard Pharmaceuticals, Inc. |
Executive VP and CFO |
Common Stock |
15,090 |
$63,378 |
$4.20 |
08 Feb 2024 |
Direct |
| TFF Pharmaceuticals, Inc. |
Director |
Common Stock |
23,165 |
$9,071 |
$0.3916 |
03 Jul 2024 |
Direct |
| TFF Pharmaceuticals, Inc. |
Director |
Restricted stock units |
5,333 |
$2,088 |
$0.3916 |
18 Apr 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
Executive VP and CFO |
Restricted Stock Unit |
0 |
$0 |
$60.00 |
02 Dec 2024 |
Direct |
| Mind Medicine (MindMed) Inc. |
Chief Financial Officer |
Stock Option (Right to Buy) |
500,000 |
|
|
02 Jun 2025 |
Direct |
| Longboard Pharmaceuticals, Inc. |
Executive VP and CFO |
Stock Option (Right to Buy) |
90,580 |
|
|
08 Feb 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
Executive VP and CFO |
Retention Restricted Stock Units |
7,900 |
|
|
25 Oct 2024 |
Direct |
| TFF Pharmaceuticals, Inc. |
Director |
Stock Options (Right to Buy) |
3,165 |
|
|
03 Jul 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
Executive VP and CFO |
Employee Stock Option (right to buy) |
0 |
|
|
02 Dec 2024 |
Direct |